Skip to content
Search

Latest Stories

NHS England to halve workforce in biggest reshaping in over a decade

NHS England to halve workforce to cut costs

“We are entering a period of critical transformation for our NHS," says Wes Streeting.

Getty Images

NHS England and the Department of Health and Social Care (DHSC) are set for significant downsizing as they strengthen collaboration under the 10-Year Health Plan to build a future-fit health service.

As part of this transformation, the NHSE workforce is expected to be reduced by up to 50% to cut costs and eliminate duplication with DHSC officials.


Confirming the plans on Monday, NHS England stated: “As part of the need to make best possible use of taxpayers’ money to support frontline services, the size of NHS England will be radically reduced and could see the size of the centre decrease by around half.”

In addition, the NHS continues to make changes to its leadership team, with three senior board members now announcing their decision to stand down at the end of March.

They are - Chief Financial Officer Julian Kelly, NHS Chief Operating Officer Emily Lawson and Chief Delivery Officer and National Director for Vaccination and Screening Steve Russell.

NHS England’s outgoing chief executive Amanda Pritchard confirmed the news in a message to all staff stating that “as part of the upcoming changes to the size and function of the centre, the board members have decided that now is the right time to step down.”

She acknowledged their contributions, saying: “It has been a privilege to work alongside Julian, Steve and Emily – they have made a huge contribution to the NHS and the country as a whole and have been an enormous source of support for me personally.

“While now is the right moment for them to move on, I know they will be missed by their colleagues – not only for their professional brilliance, but their commitment to delivering the best for patients.”

A transition team to lead the reshaping

Sir James Mackey, who will assume the role of CEO of NHS England in April, confirmed that a transition team will be established to lead the “radical reduction and reshaping” of the centre.

“We know that today’s news is unsettling for our staff, and we have significant challenges and changes ahead. We aim to have a transition team in place to start on the 1st April 2025 to help lead us through this period,” he said.

Health secretary Wes Streeting highlighted the importance of this critical transformation, stating: “With a stronger relationship between the Department for Health and Social Care and NHS England, we will work together with the speed and urgency needed to meet the scale of the challenge.”

Meanwhile, NHS England chair Richard Meddings, who will step down next month, acknowledged the departure of the three senior leaders as an “enormous loss for NHS England.”

Richard Meddings will be succeeded by Dr Penny Dash, whose four-year term begins on April 1, 2025.

Additionally, Professor Sir Stephen Powis, national medical director of NHS England, is set to step down this summer after more than seven years in the role.

NHS Confederation welcomes the decision

“These changes represent the biggest reshaping of the NHS’s national architecture in more than a decade,” said Matthew Taylor, chief executive of the NHS Confederation.

He noted that while the scale and pace at which these changes are happening were not anticipated, it is necessary to “reduce areas of duplication at a national level and for the NHS to be led by a leaner centre” given the huge savings that the NHS needs to make this year.

“NHS England has already delivered significant savings and helped to deliver improvements in productivity, but national bodies and local NHS leaders know that more is needed this year,” he added.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less